3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Breast
1
Conditions
Breast Neoplasms
218
Triple Negative Breast Neoplasms
17
Carcinoma, Intraductal, Noninfiltrating
15
Breast Neoplasms, Male
15
Inflammatory Breast Neoplasms
13
Lung Neoplasms
11
Prostatic Neoplasms
10
Neoplasms
10
Neoplasm Metastasis
10
Breast Carcinoma In Situ
9
Brain Neoplasms
9
Carcinoma, Ductal, Breast
7
Melanoma
6
Carcinoma, Non-Small-Cell Lung
6
Recurrence
5
Rectal Neoplasms
4
Radiation Injuries
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hodgkin Disease
4
Dendritic Cell Sarcoma, Interdigitating
4
Carcinoma, Renal Cell
4
Carcinoma, Lobular
4
Burkitt Lymphoma
4
Testicular Neoplasms
3
Interventions
palbociclib
2
Trastuzumab
2
Capecitabine
2
trastuzumab deruxtecan
1
tetrathiomolybdate
1
sacituzumab govitecan
1
pembrolizumab
1
niraparib
1
inavolisib
1
giredestrant
1
eribulin
1
avelumab
1
atezolizumab
1
abemaciclib
1
Zymosan
1
Radiotherapy
1
Letrozole
1
Immunotherapy
1
Hydroxychloroquine
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Radiotherapy
×
Breast
×
Clear all
NCT03945721
2025-09-29
UNITY
Massachusetts General Hospital
Phase 1
Active not recruiting
21 enrolled